Rare diseases
Investigational molecules
Locations
Via Monte Baldo 24, 37019 Peschiera Del Garda, Italy
Ospedale P. Pederzoli Casa Di Cura Privata S.p.A. in Peschiera Del Garda, Italy specialises in clinical trials of conditions such as Non-small cell lung cancer, Non-small cell lung cancer metastatic, Non-small cell lung cancer stage IV, Small cell lung cancer extensive stage, and other specialisations. This site conducts important research.
At Ospedale P. Pederzoli Casa Di Cura Privata S.p.A. researchers are focusing on metastatic non‑small cell lung cancer using modern immunotherapy approaches to improve patient outcomes.
These studies aim to determine whether adding new agents to pembrolizumab can extend survival and delay disease progression for patients with advanced lung cancer.
The site is testing innovative pairings of chemotherapy with emerging antibodies, such as ivonescimab, to treat metastatic squamous non‑small cell lung cancer.
The goal is to identify combination strategies that provide better overall survival compared with standard chemotherapy alone.
A separate line of investigation pairs sacituzumab govitecan with pembrolizumab to explore synergistic effects in patients with high PD‑L1 expression.
This research seeks to determine whether the antibody‑drug conjugate can enhance treatment durability and extend life expectancy for those with advanced lung cancer.
More sites in Peschiera Del GardaItaly
Clinical trials currently enrolling participants at this site.
Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
ItalyPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
ItalyStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
ItalyStudy of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
ItalyStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
ItalyStudy comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression
ItalyStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
ItalyAdjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC
ItalyEIK1001, Pembrolizumab, and Chemotherapy for Stage 4 Non-Small Cell Lung Cancer in Patients with Stage 4 Non-Small Cell Lung Cancer
ItalyStudy of xaluritamig plus abiraterone for men with metastatic castration-resistant prostate cancer who have not received chemotherapy
ItalyA Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment
ItalyItalyGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
